We are live on ! Find out more
JO

John Overdeck Two Sigma Investments

AUM $138B
1-Year Est. Return 41.87%
 

John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.

This Fund
S&P 500
This Quarter Est. Return
+0.36%
1 Year Est. Return
+41.87%
3 Year Est. Return
+122.61%
5 Year Est. Return
+129.48%
10 Year Est. Return
+649.67%
AUM
$29.7B
AUM Growth
-$178M
Cap. Flow
+$375M
Cap. Flow %
1.26%
Top 10 Hldgs %
6.87%
Holding
4,025
New
752
Increased
1,384
Reduced
1,238
Closed
632

Sector Composition

Rank Sector Weight
1 Technology 13.83%
2 Consumer Discretionary 13.24%
3 Healthcare 9.85%
4 Financials 9.55%
5 Industrials 8.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GPOR
3376
CALL
DELISTED
Gulfport Energy Corp.
GPOR
$30K ﹤0.01%
11,000
-6,000
-35% -$20K
MRIN
3377
DELISTED
Marin Software
MRIN
$29K ﹤0.01%
1,912
-733
-28% -$10.6K
VIVS
3378
VivoSim Labs
VIVS
$3.91M
$27K ﹤0.01%
439
+76
+21% +$6.4K
REKR icon
3379
Rekor Systems
REKR
$80.3M
$24K ﹤0.01%
+11,262
New +$34.2K
INDP icon
3380
Indaptus Therapeutics
INDP
$155M
$23K ﹤0.01%
14
-36
-72% -$107K
SCYX icon
3381
SCYNEXIS
SCYX
$52.3M
$22K ﹤0.01%
+259
New +$23.7K
VSA
3382
VisionSys AI
VSA
$9.64M
$22K ﹤0.01%
9
-9
-50% -$30.9K
CHAP
3383
DELISTED
Chaparral Energy, Inc.
CHAP
$22K ﹤0.01%
+16,514
New +$45.7K
RNAC icon
3384
Cartesian Therapeutics
RNAC
$304M
$20K ﹤0.01%
+387
New +$20.6K
TYME
3385
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$20K ﹤0.01%
16,694
-56,861
-77% -$71.7K
SNNA
3386
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
$17K ﹤0.01%
83,579
-77,788
-48% -$52.7K
PDS
3387
Precision Drilling
PDS
$1.13B
$13K ﹤0.01%
578
-3,369
-85% -$98.2K
SISI
3388
DELISTED
Shineco
SISI
0
CENN icon
3389
Cenntro
CENN
$9.87M
0
MTNB icon
3390
Matinas BioPharma
MTNB
$2.89M
$7K ﹤0.01%
+225
New +$8.13K
TRIL
3391
DELISTED
Trillium Therapeutics Inc.
TRIL
$7K ﹤0.01%
24,138
-2,300
-9% -$777
AAPL icon
3392
Apple
AAPL
$4.53T
-889,996
Closed -$46.5M
ACGL icon
3393
Arch Capital
ACGL
$34.5B
-26,881
Closed -$997K
ACM icon
3394
Aecom
ACM
$8.36B
-174,594
Closed -$6.61M
ACN icon
3395
CALL
Accenture
ACN
$114B
-2,000
Closed -$370K
ACN icon
3396
PUT
Accenture
ACN
$114B
-2,000
Closed -$370K
ACRS icon
3397
Aclaris Therapeutics
ACRS
$929M
-71,581
Closed -$157K
ADMA icon
3398
ADMA Biologics
ADMA
$2.14B
-54,334
Closed -$210K
ADNT icon
3399
CALL
Adient
ADNT
$1.46B
-29,600
Closed -$718K
ADP icon
3400
CALL
Automatic Data Processing
ADP
$112B
-7,000
Closed -$1.16M

Similar funds

John Overdeck's Q3 2019 Portfolio in Review

As of Q3 2019, John Overdeck held 4,025 positions worth $29.7B, down 0.59% from $29.9B the previous quarter. Its ten largest holdings account for 6.9% of the portfolio.

John Overdeck's Q3 2019 filing shows 752 new, 1,384 increased, 1,238 reduced and 632 closed positions. Its largest new stake was Kohl's: 2,193,475 shares worth $109M. The largest sale was Dollar Tree, an estimated $157M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • John Overdeck's largest Q3 2019 buy was Kohl's: 2,193,475 shares worth $109M.
  • John Overdeck added most to Chevron in Q3 2019, an estimated $153M increase.
  • John Overdeck's biggest Q3 2019 reduction was Dollar Tree, cutting an estimated $157M.
  • John Overdeck fully exited Activision Blizzard in Q3 2019, selling an estimated $137M.
  • John Overdeck's ten largest holdings make up 6.9% of its $29.7B portfolio in Q3 2019.
  • John Overdeck opened 752 new positions and closed 632 in Q3 2019.
  • John Overdeck's portfolio value fell 0.59% quarter-over-quarter to $29.7B.

Based on Two Sigma Investments's 13F filing for Q3 2019, filed 14 Nov 2019.